UK markets closed

Capricor Therapeutics, Inc. (CAPR)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
4.9900-0.0500 (-0.99%)
As of 12:43PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,592
25,178
2,551
244.898
310.25
Operating expenses
Research development
19,849
36,448
21,817
13,571
8,457
Selling general and administrative
9,754
12,366
10,319
7,612
5,543
Total operating expenses
29,602
49,256
32,249
21,183
14,000
Operating income or loss
-28,011
-24,078
-29,697
-20,938
-13,690
Total other income/expenses net
521.536
1,790
677.851
915.922
32.943
Income before tax
-27,489
-22,288
-29,020
-20,023
-13,657
Income from continuing operations
-27,489
-22,288
-29,020
-20,023
-13,657
Net income
-27,489
-22,288
-29,020
-20,023
-13,657
Net income available to common shareholders
-27,489
-22,288
-29,020
-20,023
-13,657
Basic EPS
-1.16
-0.83
-1.18
-0.87
-0.88
Diluted EPS
-1.16
-0.83
-1.18
-0.87
-0.88
Basic average shares
25,394
26,778
24,553
23,089
15,571
Diluted average shares
25,394
26,778
24,553
23,089
15,571